Clarithromycin attenuates myocardial ischemiareperfusion injury

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 9, 2010, Pages 881-893

  Nakajima, Takuya ^a   Hishikari, Keiichi ^a   Ogawa, Masahito ^b   Watanabe, Ryo ^a   Suzuki, Jun Ichi ^b   Nagashima, Ayako ^a   Masumura, Mayumi ^a   Takayama, Kiyoshi ^c   Hirata, Yasunobu ^b   Nagai, Ryozo ^b   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NB Health Laboratory   (Japan)

Author keywords

Antibiotics; Inflammation; Ischemia; Metalloproteinase; Remodeling; Reperfusion injury

Indexed keywords

CLARITHROMYCIN; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HEART INFARCTION SIZE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART RATE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SURVIVAL;

ANIMALS; CLARITHROMYCIN; FIBROSIS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955438467     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2010.502890     Document Type: Article

References (35)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;14:1121-1135
2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172 (Pubitemid 20119612)
3. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47
4. Yamamoto T, Eckes B, Mauch C, et al. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1alpha loop. J Immunol 2000;164:6174-6179 (Pubitemid 30408794)
5. Leppert D, Waubant E, Galardy R, et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-4389
6. Xia M, Leppert D, Hauser SL, et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 1996;156:160-167 (Pubitemid 26006959)
7. Hibbs MS, Hoidal JR, Kang AH. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 1987;80:1644-1650
8. Hashimoto N, Kawabe T, Hara T, et al. Effect of erythromycin on matrix metalloproteinase-9 and cell migration. J Lab Clin Med 2001;137:176-183 (Pubitemid 32203197)
9. Lalu MM, Pasini E, Schulze CJ, et al. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur Heart J 2005;26:27-35 (Pubitemid 40221120)
10. Deschamps AM, Yarbrough WM, Squires CE, et al. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Circulation 2005;111:1166-1174
11. Stapel H, Kim SC, Osterkamp S, et al. Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: role of matrix metalloproteinases. Eur J Heart Fail 2006;8:665-672 (Pubitemid 44635319)
12. Lindsey M, Wedin K, Brown MD, et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 2001;103:2181-2187 (Pubitemid 32458328)
13. Ogawa M, Suzuki J, Hishikari K, et al. Clarithromycin attenuates acute and chronic rejection via MMP suppression in murine cardiac transplantation. J Am Coll Cardiol 2008;51:1977-1985 (Pubitemid 351636452)
14. Hishikari K, Watanabe R, Ogawa M, et al. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity. Heart 2010;96:523-527
15. Onai Y, Suzuki J, Kakuta T, et al. Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res 2004;63:51-59 (Pubitemid 38759809)
16. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994;89:345-354 (Pubitemid 24026509)
17. Suzuki J, Ogawa M, Futamatsu H, et al. A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. J Mol Cell Cardiol 2006;40:688-695
18. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985;121:522-530
19. Yamashiro S, Takeya M, Kuratsu J, et al. Intradermal injection of monocyte chemoattractant protein-1 induces emigration and differentiation of blood monocytes in rat skin. Int Arch Allergy Immunol 1998;115:15-23 (Pubitemid 28017655)
20. Suzuki J, Ogawa M, Sagesaka YM, Isobe M. Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. Cardiovasc Res 2006;69:272-279 (Pubitemid 41814828)
21. Cheung PY, Sawicki G, Wozniak M, et al. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 2000;101:1833-9 (Pubitemid 30213106)
22. Wright JW, Brown TE, Harding JW. Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory. Neural Plast 2007;2007:73813
23. Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J 2004;23:671-678 (Pubitemid 38618134)
24. Kagawa N, Senbonmatsu TA, Satoh K, et al. Tetracycline protects myocardium against ischemic injury. Front Biosci 2005;10:608-619
25. Gu Y, Lee HM, Golub LM, et al. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines. Ann Med 2005;37:450-460 (Pubitemid 41476130)
26. Grenier D, Plamondon P, Sorsa T, et al. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives. J Periodontol 2002;73:79-85 (Pubitemid 34213462)
27. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction:a new approach to prevent heart failure? Circ Res 2001;89:201-210
28. Kandasamy AD, Chow AK, Ali MA, Schulz R. Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res 2010;85:413-423
29. Papadopoulos DP, Economou EV, Makris TK, et al. Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction. Drugs Exp Clin Res 2004;30:55-65
30. Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res 2007;74:343-355
31. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47
32. Giannelli G, Falk-Marzillier J, Schiraldi O, et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997;277:225-228 (Pubitemid 27446075)
33. Mazzarella G, Petillo O, Margarucci S, et al. Role of monocyte/macrophage population in immune response. Monaldi Arch Chest Dis 1998;53:92-96 (Pubitemid 28239306)
34. Sawicki G, Leon H, Sawicka J, et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 2005;112:544-552 (Pubitemid 41060795)
35. Nakanishi Y, Kobayashi D, Asano Y, et al. Clarithromycin prevents smoke-induced emphysema in mice. Am J Respir Crit Care Med 2009;179:271-278